全文获取类型
收费全文 | 1326935篇 |
免费 | 99070篇 |
国内免费 | 5048篇 |
专业分类
耳鼻咽喉 | 19014篇 |
儿科学 | 42901篇 |
妇产科学 | 38401篇 |
基础医学 | 193950篇 |
口腔科学 | 36398篇 |
临床医学 | 114431篇 |
内科学 | 259764篇 |
皮肤病学 | 27261篇 |
神经病学 | 102288篇 |
特种医学 | 52556篇 |
外国民族医学 | 387篇 |
外科学 | 203242篇 |
综合类 | 32678篇 |
现状与发展 | 14篇 |
一般理论 | 305篇 |
预防医学 | 95492篇 |
眼科学 | 30272篇 |
药学 | 103158篇 |
39篇 | |
中国医学 | 4913篇 |
肿瘤学 | 73589篇 |
出版年
2018年 | 13788篇 |
2017年 | 10688篇 |
2016年 | 11833篇 |
2015年 | 14204篇 |
2014年 | 19006篇 |
2013年 | 27256篇 |
2012年 | 37710篇 |
2011年 | 40352篇 |
2010年 | 23940篇 |
2009年 | 22182篇 |
2008年 | 37838篇 |
2007年 | 40730篇 |
2006年 | 41096篇 |
2005年 | 40279篇 |
2004年 | 38185篇 |
2003年 | 37018篇 |
2002年 | 36297篇 |
2001年 | 59104篇 |
2000年 | 60597篇 |
1999年 | 51739篇 |
1998年 | 14822篇 |
1997年 | 13387篇 |
1996年 | 13531篇 |
1995年 | 12752篇 |
1994年 | 12124篇 |
1993年 | 11065篇 |
1992年 | 41302篇 |
1991年 | 40604篇 |
1990年 | 40129篇 |
1989年 | 38921篇 |
1988年 | 36312篇 |
1987年 | 35515篇 |
1986年 | 33863篇 |
1985年 | 32243篇 |
1984年 | 23991篇 |
1983年 | 20873篇 |
1982年 | 12398篇 |
1981年 | 10961篇 |
1979年 | 22667篇 |
1978年 | 15893篇 |
1977年 | 13748篇 |
1976年 | 12999篇 |
1975年 | 14214篇 |
1974年 | 16698篇 |
1973年 | 16091篇 |
1972年 | 15331篇 |
1971年 | 14238篇 |
1970年 | 13223篇 |
1969年 | 12740篇 |
1968年 | 11984篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
人工智能(Artificial Intelligence,AI)的蓬勃兴起为现代社会带来了前所未有的机遇,中医药是中华民族传承千年的文化瑰宝。随着人工智能技术不断在中医药领域的科技创新中崭露头角,二者的融合不断加深,人工智能在中医药领域的发展前景、争议挑战也引发了诸多思考。本文将从人工智能在中医药领域的应用入手,对人工智能辅助中医诊断、智能决策与数据挖掘、健康管理及中草药现代化研究等方面,就近年来国内外研究进展进行总结与分析,以期为AI视域下实现中医药现代化、智能化赋能。 相似文献
4.
5.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
6.
Timothy J. Cordingley Mark A.G. Wilson Kathryn M. Weston 《Health & social care in the community》2022,30(1):353-359
Vaccination is a vital health care initiative to prevent individual and population infection. To increase vaccination rates the federal government implemented the ‘No Jab, No Pay’ policy, where eligibility for several government benefits required children to be fully vaccinated by removing ‘conscientious objections’ and expanding the age range of children whose families receive benefits. This study assesses the impact of this policy at a local area within a single medical practice community in NSW, Australia. A retrospective clinical audit was performed between 2012 and 2017 on a single general practice's vaccination records for children ≤19 years. Catch-up vaccinations were assessed based on age at vaccination. Incidence of catch-up vaccinations was assessed for each of four years before and two years after the implementation of the ‘No Jab, No Pay’ policy in January 2016, along with the age of children and vaccination(s) given. Catch-up vaccinations were assessed temporally either side of implementation of ‘No Jab, No Pay’. Comparing the average annual vaccination catch-up incidence rate of 6.2% pre-implementation (2012–2015), there was an increase to 9.2% in 2016 (p < .001) and 7.8% in 2017 (p = .027). Secondary outcome measurement of catch-up vaccination incidence rates before (2012–2015) and after (2016–2017) ‘No Jab, No Pay’ implementation showed statistically significant increases for children aged 8–11 years (3.2%–5.6%, p = .038), 12–15 years (7.5%–14.7%, p < .001) and 16–19 years (3.3%–10.2%, p < .001) along with a statistically significant reduction in children aged 1–3 years (11.4%–6.2%, p = .015). Also, catch-up rates for DTPa significantly increased after program implementation. This study demonstrates that the Australian federal government vaccination policy ‘No Jab, No Pay’ was coincident with an increase in catch-up vaccinations within a rural NSW community served by one medical practice, especially for older children. 相似文献
7.
目的:探讨姑息性胃切除联合术后化疗评分在腹膜转移的胃癌患者预后评估中的临床意义。方法:回顾性分析2010年1月至2016年12月7年间收治的287例发生腹膜转移的胃癌患者的临床病理资料。通过χ2检验分析评分与患者临床病理因素间的关系。通过Kaplan-Meier法绘制生存曲线,Log-rank检验比较患者生存率的差异;采用Cox比例风险回归模型对患者进行预后分析。结果:与评分中得分为2分和1分的患者相比,得分为0分的患者肿瘤侵润至T4b 期的患者较少[31%(18/58)比50.8%(63/124)、56.2%(59/105),P=0.039]。全组患者的中位生存时间仅为8.7月。对患者进行单因素预后分析结果显示,血清白蛋白浓度(≤40 g/L),腹水,腹膜转移范围较大,肿瘤T分期较晚,评分得分较高的患者预后较差(均P<0.05)。将上述因素纳入Cox多因素分析结果显示:评分[HR(95%CI):1.384(1.165~1.644),P=0.000],血清白蛋白浓度[HR(95%CI):0.759(0.593~0.971),P=0.028],肿瘤T分期[HR(95%CI):1.493(1.216~1.832),P=0.000]是患者预后的独立危险因素。结论:评分对于胃癌伴腹膜转移患者的预后生存评估具有重要的临床意义。 相似文献
8.
10.
Platelets are needed to prevent or arrest bleeding and aggregate at the site of injury upon vascular damage. Platelets express receptors for estrogens which might affect the function of the platelets and their hemostatic ability. The aim was to identify possible differences in platelet function related to age, gender, and phases of the menstrual cycle by use of impedance aggregometry with Multiplate. In the first part of the study, platelet function was assessed in 60 healthy individuals (30 men and 30 women) in each of three age groups (20–25, 40–45, and 60–65 years). In the second part of the study, the platelet function was analyzed on four occasions during the menstrual cycle in women without oral contraceptives (OCs) (n = 17) and compared to 19 women on OCs and 18 men of similar age (20–40 years). For the women on OCs, aggregation was analyzed once during the tablet-free week and once late during the period with OCs. The men were sampled once. Women of younger age (<45 years) had significantly higher agonist-induced aggregation response than both men and post-menopausal women (60–65 years). The agonist-induced aggregation response did not differ between phases of the menstrual cycle or OC use. The results suggest that estradiol and/or progesterone affect spontaneous aggregation since it was found to be lowest in the mid-luteal phase. Spontaneous aggregation was significantly lower in women on OCs than in both men and women without OCs. Our findings indicate that fertile age is associated with higher aggregation response capacity of the platelets, possibly to prevent excessive bleeding during menstruation, but this response capacity is not altered during the menstrual cycle or by use of OCs. 相似文献